Rhythm Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $7.57 billion, with shareholders equity totaling $87.97 million.
The company employs approximately 90 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Rhythm Pharmaceuticals Inc. reported $280.75 million in revenue, generating net income of $-193.81 million.
Key financial metrics include a P/E ratio of -39.06, a price-to-book (P/B) ratio of 86.05, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker RYTM.